Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Poseida Therapeutics
Research
Poseida gene therapy reduces kallikrein protein levels in mice
At the minimally effective dose of 0.125 milligrams per kilogram, kallikrein levels were reduced in the mouse model by 58%, the company said.
Darren Incorvaia
Oct 24, 2024 1:20pm
Astellas hops into Poseida's car for $50M cell therapy collab
May 1, 2024 12:49pm
Poseida examines CAR-T conditioning to crack into solid tumors
Apr 10, 2024 10:32am
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Mar 29, 2024 9:30am
Poseida makes case for safety of Roche-partnered nonviral CAR-T
Dec 10, 2023 12:00pm
CEPI's founding CEO to lead Wellcome—Chutes & Ladders
Oct 13, 2023 9:30am
